Skip to content

Dry Needling for Cervicogenic Headache

Dry Needling of the Trigeminal Nerve Innervation Field for Cervicogenic Eadache: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05140291
Enrollment
30
Registered
2021-12-01
Start date
2021-12-03
Completion date
2022-04-30
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache

Brief summary

Currently, it is unknown if dry needling when performed to the trigeminal innervation field improves neck pain and or headache for patients with cervicogenic headaches. The aim of this study is to determine if dry needling of the trigeminal innervation field improves pain, pain-pressure thresholds, and neck mobility in patients with cervicogenic headaches, with or without migraine.

Detailed description

Dry needling is a widely used intervention performed by physical therapists for a wide range of musculoskeletal and neurological conditions. Dry needling has been shown to be beneficial for cervicogenic headaches but treatment is typically applied to the neck. It is well-established that cervical pain can upregulate the trigeminal nerve and vice versa in various forms of headaches. Thus, it is plausable that reducing inflammation and irritation of the trigeminal nerve may in fact reduce neck pain and impairments. This study aims to look investigate whether dry needling the trigeminal innervation field will reduce pain and impairments known to exist in patients with cervicogenic headaches compared to a sham comparator. The study is a pilot trial for a larger RCT and will look at immediate effects only.

Interventions

OTHERDry Needling

1/2 needles will placed into defined innervation fields of the trigeminal nerve and rotated. Total time will be 5-7 minutes.

OTHERSham Dry Needling

Needle handles inside of guide tubes will be tapped in a way similar to an actual needle being set but the sham needles will be blunted.

Sponsors

Youngstown State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Patients will be asked to keep their eyes closed during the treatment. Clinicians will be blinded to group and outcomes

Intervention model description

Double blinded, sham controlled, randomized trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 or older * Symptoms: (1)Unilateral pain starting in the neck and radiating to the frontotemporal region or posterior fossa, (2) pain aggravated by neck movement, (3) restricted cervical range of motion, (4) non-throbbing and non-lancinatingnpain, 5) dysfunction/headache pain in at least one of the joints of the upper cervical spine(C0-C4), and (6) headache frequency of at least 1 per week over a period greater than 3 months.

Exclusion criteria

* Pain \<2/10 * Contraindications to the interventions * Whiplash associated disorder within 6 weeks * Pending litigation for neck pain and/or headache.

Design outcomes

Primary

MeasureTime frameDescription
Headache or neck pain intensity on a Numeric pain rating scale (0-10)<1 hour0-10 scale pain intensity

Secondary

MeasureTime frameDescription
Active Range of Motion of the Cervical Spine in degrees of measurement<1 hourActive range of motion will be measured in the most painful and or limited plane of movement.
Flexion-rotation test in degrees of measurement<1 hourFlexion-rotation test for CGH will be measured to determine any change in measure for c1-c2 mobility.
Pain-pressure threshold in lbs of pressure<1 hourPain-pressure threshold will be measured using an algometer at the innervation zones of the trigeminal nerve and the upper cervical spine.

Countries

United States

Contacts

Primary ContactDavid W Griswold, PhD
dwgriswold@ysu.edu3307015353

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026